Central Cancer Registry Reporting Content IG, published by HL7 International / Public Health. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-central-cancer-registry-reporting-ig/ and changes regularly. See the Directory of published versions
Bundle ccrr-non-encounter-based-content-bundle-example of type collection
Entry 1 - fullUrl = http://hl7.org/fhir/us/central-cancer-registry-reporting/Composition/ccrr-composition-non-encounter-content-example
Resource Composition:
Non-encounter Based Example
Entry 2 - fullUrl = http://hl7.org/fhir/us/central-cancer-registry-reporting/Practitioner/1
Resource Practitioner:
Profile: US Core Practitioner
Practitioner: Dr. Joseph Nichols
Identifier: US NPI: 1122334455
Address: 1234 Main St., Tulsa, OK 74126, US (work)
Email: joseph.nichols@example.com
Phone: 800-277-1993
Entry 3 - fullUrl = http://hl7.org/fhir/us/central-cancer-registry-reporting/Condition/primary-cancer-condition-breast
Resource Condition:
Profile: Central Cancer Registry Primary Cancer Condition
Condition: Primary Breast Cancer
Clinical Status: Active
Verification Status: Confirmed
Category: Encounter Diagnosis
Code: Infiltrating duct carcinoma of breast (SNOMED CT: 408643008)
Histology/Morphology/Behavior: Infiltrating duct carcinoma (morphologic abnormality) (SNOMED CT: 82711006)
Body Site: Left breast structure (SNOMED CT: 80248007)
Laterality: Left (qualifier value) (SNOMED CT: 7771000)
Subject: Patient-example: Amy Shaw
Asserter: Dr. Joseph Nichols
Asserted Date: 2023-03-21
Stage Summary: American Joint Committee on Cancer stage IIA (qualifier value) (SNOMED CT: 1222766008)
Evidence Type: Histologic test (procedure) (SNOMED CT: 714797009)
Entry 4 - fullUrl = http://hl7.org/fhir/us/central-cancer-registry-reporting/MedicationAdministration/cancer-med-admin-docetaxel-example
Resource MedicationAdministration:
Profile: mCODE Cancer Related Medication Administration
status: completed
category: Outpatient
medication: rxnorm 72962 docetaxel
subject: Patient-example: Amy Shaw
start date: 2023-04-10
Performer: Joseph Nichols
reasonReference: Condition-primary-cancer-condition-breast
authoredOn: 2023-04-10
note: Chemotherapy regimen of docetaxel, carboplatin, adriamycin, cyclophosphamide, and paclitaxel administered by continuous infusion. Patient tolerated infusion without side effects.
Route: SNOMED 47625008 Intravenous route (qualifier value)
Entry 5 - fullUrl = http://hl7.org/fhir/us/central-cancer-registry-reporting/Organization/example-cancer-org
Resource Organization:
Profile: Central Cancer Registry Reporting Organization
Organization: Cancer Organization
Status: Active
Identifier (NPI): 1063494177
Address: 1234 Main Street, Tulsa, OK 74126
Phone: (917)932-2000